-
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| ISIN | US74276L1052 |
| Sector | Healthcare |
| Industry | Medical Devices |
| Beta | 1.08 |
|---|---|
| Market Cap | 3B |
| PE Ratio | None |
| Target Price | 90.875 |
| Dividend Yield | None |
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for PRCT using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025